Suchergebnisse - "Balagula, Yevgeniy"

PubPharm (75)

71

Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)

enthalten in: Investigational new drugs | 2010

von Balagula, Y. | Barth Huston, K. | Busam, K. | +3

72

Dermatologic toxicities of targeted anticancer therapies

enthalten in: The journal of supportive oncology | 2010

von Balagula, Y. | Lacouture, M. | Cotliar, J.

CommentIn: J Support Oncol. 2010 Jul-Aug;8(4):162-3. - PMID 20822033

73

Photodermatosis associated with eculizumab (Soliris) : a novel monoclonal antibody directed against the complement protein C5

enthalten in: American journal of hematology | 2010

von Balagula, Y. | Newman, S. | Lacouture, M.

74

Photoprotection : a review of the current and future technologies

enthalten in: Dermatologic therapy | 2010

von Wang, S. | Balagula, Y. | Osterwalder, U.

75

Photoprotection: a Review of the Current and Future Technologies

enthalten in: Dermatologic therapy | 2010

von Wang, S. | Balagula, Y. | Osterwalder, U.

[1]
« Vorheriger
1
2
3
4
5
6
7
8